Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Use of FSHR p.N680S polymorphism to choose exogenous FSH dose in controlled ovarian hyperstimulation
2016-004114-99Phase 4Terminated
- Sponsor
- AB-BIOTICS
- Start
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of follicle-stimulating hormone in infertility, sponsored by AB-BIOTICS. Primary endpoint: Number of follicles on rHCG administration day. Started Dec 2016; status: terminated.
02
Drugs
follicle-stimulating hormone
03
Conditions
infertility
Beyond the preview
Go deeper on 2016-004114-99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004114-99.